These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 36086315)
1. Glucose Prediction using Wide-Deep LSTM Network for Accurate Insulin Dosing in Artificial Pancreas. Kalita D; Mirza KB Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():4426-4429. PubMed ID: 36086315 [TBL] [Abstract][Full Text] [Related]
2. InsNET: Accurate Basal and Bolus Insulin Dose Prediction for Closed Loop Diabetes Management. Kalita D; Mirza KB Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083208 [TBL] [Abstract][Full Text] [Related]
3. Diabetes technology and treatments in the paediatric age group. Shalitin S; Peter Chase H Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816 [TBL] [Abstract][Full Text] [Related]
4. Continuous Glucose, Insulin and Lifestyle Data Augmentation in Artificial Pancreas Using Adaptive Generative and Discriminative Models. Kalita D; Sharma H; Mirza KB IEEE J Biomed Health Inform; 2024 Aug; 28(8):4963-4974. PubMed ID: 38709612 [TBL] [Abstract][Full Text] [Related]
5. Stacked LSTM based deep recurrent neural network with kalman smoothing for blood glucose prediction. Rabby MF; Tu Y; Hossen MI; Lee I; Maida AS; Hei X BMC Med Inform Decis Mak; 2021 Mar; 21(1):101. PubMed ID: 33726723 [TBL] [Abstract][Full Text] [Related]
6. Platform for precise, personalised glucose forecasting through continuous glucose and physical activity monitoring and deep learning. Kalita D; Sharma H; Panda JK; Mirza KB Med Eng Phys; 2024 Oct; 132():104241. PubMed ID: 39428134 [TBL] [Abstract][Full Text] [Related]
7. Multi-Hour Blood Glucose Prediction in Type 1 Diabetes: A Patient-Specific Approach Using Shallow Neural Network Models. Kushner T; Breton MD; Sankaranarayanan S Diabetes Technol Ther; 2020 Dec; 22(12):883-891. PubMed ID: 32324062 [No Abstract] [Full Text] [Related]
8. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review. Matsuda E; Brennan P JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140 [TBL] [Abstract][Full Text] [Related]
9. Hypoglycaemia incidence and recovery during home use of hybrid closed-loop insulin delivery in adults with type 1 diabetes. Ruan Y; Bally L; Thabit H; Leelarathna L; Hartnell S; Tauschmann M; Wilinska ME; Evans ML; Mader JK; Kojzar H; Dellweg S; Benesch C; Arnolds S; Pieber TR; Hovorka R Diabetes Obes Metab; 2018 Aug; 20(8):2004-2008. PubMed ID: 29577536 [TBL] [Abstract][Full Text] [Related]
10. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability. Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925 [TBL] [Abstract][Full Text] [Related]
11. Closed loop insulin delivery in diabetes. Battelino T; Omladič JŠ; Phillip M Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293 [TBL] [Abstract][Full Text] [Related]
12. Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes. Woldaregay AZ; Årsand E; Walderhaug S; Albers D; Mamykina L; Botsis T; Hartvigsen G Artif Intell Med; 2019 Jul; 98():109-134. PubMed ID: 31383477 [TBL] [Abstract][Full Text] [Related]
13. Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective? Boughton CK; Hovorka R Diabet Med; 2019 Mar; 36(3):279-286. PubMed ID: 30183096 [TBL] [Abstract][Full Text] [Related]
14. [Closed-loop systems - Update 2020]. Melmer A; Tripyla A; Herzig D; Laimer M; Stettler C; Bally L Ther Umsch; 2020 Sep; 77(7):312-318. PubMed ID: 32996429 [TBL] [Abstract][Full Text] [Related]
15. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. Rodbard D Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879 [TBL] [Abstract][Full Text] [Related]
17. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709 [TBL] [Abstract][Full Text] [Related]
18. Incorporating Glucose Variability into Glucose Forecasting Accuracy Assessment Using the New Glucose Variability Impact Index and the Prediction Consistency Index: An LSTM Case Example. Mosquera-Lopez C; Jacobs PG J Diabetes Sci Technol; 2022 Jan; 16(1):7-18. PubMed ID: 34490793 [TBL] [Abstract][Full Text] [Related]
19. Coming of age: the artificial pancreas for type 1 diabetes. Thabit H; Hovorka R Diabetologia; 2016 Sep; 59(9):1795-805. PubMed ID: 27364997 [TBL] [Abstract][Full Text] [Related]
20. How Much Is Short-Term Glucose Prediction in Type 1 Diabetes Improved by Adding Insulin Delivery and Meal Content Information to CGM Data? A Proof-of-Concept Study. Zecchin C; Facchinetti A; Sparacino G; Cobelli C J Diabetes Sci Technol; 2016 Sep; 10(5):1149-60. PubMed ID: 27381030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]